Sign in

CIK 0001520262 · Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981007018
Phone
00-353-1-772-8000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,070,874
in 5 filings, $1.1M under 10b5-1 plans

Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hopkinson Craig C. −$423K EVP R&D, Chief Medical Officer sold 12% of stake
  2. Nichols Christian Todd −$373K SVP, Chief Commercial Officer sold 7% of stake
  3. Gaffin David Joseph −$275K EVP, CLO, Alkermes, Inc. sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-22 Brown Iain Michael SVP, Chief Financial Officer Option exercise · Restricted Stock Unit Award −6,969 13,939
2023-02-21 POPS RICHARD F Director and CEO, Alkermes plc Option exercise +32,400 1,067,267
2023-02-21 POPS RICHARD F Director and CEO, Alkermes plc Shares withheld for taxes −14,386 $27.77 $399K 1,052,881
2023-02-21 POPS RICHARD F Director and CEO, Alkermes plc Option exercise · Restricted Stock Unit Award −32,400 0
2023-02-21 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Option exercise +5,825 249,947
2023-02-21 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Shares withheld for taxes −2,587 $27.77 $72K 247,360
2023-02-21 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Option exercise · Restricted Stock Unit Award −5,825 0
2023-02-21 Jackson Blair Curtis EVP, Chief Operating Officer Option exercise +4,800 109,113
2023-02-21 Jackson Blair Curtis EVP, Chief Operating Officer Shares withheld for taxes −1,412 $27.77 $39K 107,701
2023-02-21 Jackson Blair Curtis EVP, Chief Operating Officer Option exercise · Restricted Stock Unit Award −4,800 0
2023-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Option exercise +6,875 52,919
2023-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Shares withheld for taxes −3,053 $27.77 $85K 49,866
2023-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Option exercise · Restricted Stock Unit Award −6,875 0
2023-02-21 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Option exercise +6,875 124,813
2023-02-21 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Shares withheld for taxes −2,022 $27.77 $56K 122,791
2023-02-21 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Option exercise · Restricted Stock Unit Award −6,875 0
2023-02-21 Brown Iain Michael SVP, Chief Financial Officer Option exercise +4,800 79,330
2023-02-21 Brown Iain Michael SVP, Chief Financial Officer Shares withheld for taxes −1,412 $27.77 $39K 77,918
2023-02-21 Brown Iain Michael SVP, Chief Financial Officer Option exercise · Restricted Stock Unit Award −4,800 0
2023-02-20 POPS RICHARD F Director and CEO, Alkermes plc Grant or award +119,713 1,088,012

Page 44 of 60 · 1,194 trades